Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Washington, DC
SEC filing record 1 source field available
Fiscal year end
31 December
Vanda Pharmaceuticals Inc. has filed 1,327 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 51-75 of 954 matching filings.

Per page
25
Current page
3
SCHEDULE 13G/A File 005-82196

SCHEDULE 13G/A filing

Filing date
21 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-82196

SCHEDULE 13G/A filing

Filing date
09 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Aug 2025
Reporting date
07 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-82196

SCHEDULE 13G filing

Filing date
01 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Jun 2025
Reporting date
13 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-34186

144 filing

Filing date
13 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-34186

DEFA14A

Filing date
27 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 May 2025
Reporting date
21 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .